Papers by Petar Seferović
Page 2 · newest first
- Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failureAmerican Heart Journal · 2023
- Incidence, Risk Assessment and Prevention of Sudden Cardiac Death in CardiomyopathiesEuropean Journal of Heart Failure · 2023
- Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus reportInternational Journal of Cardiology · 2023
- Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress Using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESCEuropean Journal of Heart Failure · 2023
- Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2023
- Decongestion Strategies In Patients Presenting with Acutely Decompensated Heart Failure: A Worldwide Survey Among PhysiciansEuropean Journal of Heart Failure · 2023
- State-of-the-Art Document on Optimal Contemporary Management of CardiomyopathiesEuropean Journal of Heart Failure · 2023
- Prevalence, Clinical Characteristics and Outcomes of Heart Failure Patients with or Without Isolated or Combined Mitral and Tricuspid Regurgitation: An Analysis from the ESC-HFA Heart Failure Long-Term RegistryEuropean Journal of Heart Failure · 2023
- International validation of the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score in heart failureEuropean Journal of Preventive Cardiology · 2023
- Acute Heart Failure and Valvular Heart Disease: A Scientific Statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of CardiologyEuropean Journal of Heart Failure · 2023
- Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term RegistryEuropean Journal of Heart Failure · 2023
- Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of HypertensionEuropean Journal of Heart Failure · 2023
- Pre-Discharge and Early Post-Discharge Management of Patients Hospitalized for Acute Heart Failure: A Scientific Statement by the Heart Failure Association of the ESCEuropean Journal of Heart Failure · 2023
- Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term RegistryEuropean Journal of Preventive Cardiology · 2023
- Hyponatraemia and Changes in Natraemia During Hospitalization for Acute Heart Failure and Associations with In-Hospital and Long-Term Outcomes – from the ESC-HFA EORP Heart Failure Long-Term RegistryEuropean Journal of Heart Failure · 2023
- Worsening of Chronic Heart Failure: Definition, Epidemiology, Management and Prevention. A Clinical Consensus Statement by the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2023
- Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure SocietyEuropean Journal of Heart Failure · 2023
- Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessmentJournal of Scleroderma and Related Disorders · 2023
- Inotropic Therapy in Patients with Advanced Heart Failure. A Clinical Consensus Statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2023
- Heart Failure Association/European Society of Cardiology Atlas second edition: new insights into understanding the burden of heart failureEuropean Heart Journal · 2022
- Haemodynamic determinants of quality of life in chronic heart failureBMC Cardiovascular Disorders · 2022
- Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2022
- Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of CardiologyEuropean Journal of Heart Failure · 2022
- Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetesCardiovascular Diabetology · 2022
- Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trialEuropean Journal of Heart Failure · 2022
- Impact Analysis of Heart Failure Across European Countries: An ESC-HFA Position PaperESC Heart Failure · 2022
- Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular ImagingEuropean Heart Journal - Cardiovascular Imaging · 2022
- Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter‐defibrillator for primary prevention?European Journal of Heart Failure · 2022
- Head‐to‐head comparison between recommendations by the ESC and ACC / AHA / HFSA heart failure guidelinesEuropean Journal of Heart Failure · 2022
- Medical Treatment of Heart Failure with Reduced Ejection Fraction in the ElderlyCardiac failure review · 2022
- Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2022
- Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2022
- Data standards for heart failure: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)European Heart Journal · 2022
- Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2022
- Global burden of heart failure: a comprehensive and updated review of epidemiologyCardiovascular Research · 2022
- Education and certification on heart failure of the H eart F ailure A ssociation of the E uropean S ociety of C ardiologyEuropean Journal of Heart Failure · 2022
- European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2022
- Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive CardiologyEuropean Journal of Heart Failure · 2022
- Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)European Journal of Heart Failure · 2021
- A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC‐HFA EORP Heart Failure Long‐Term RegistryEuropean Journal of Heart Failure · 2021
- Feasibility of the cardiac output response to stress test in suspected heart failure patientsFamily Practice · 2021
- Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fractionEuropean Journal of Heart Failure · 2021
- Sodium–glucose co‐transporter 2 inhibitors as an early, first‐line therapy in patients with heart failure and reduced ejection fractionEuropean Journal of Heart Failure · 2021
- European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosisCardiovascular Research · 2021
- Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of CardiologyEuropean Heart Journal · 2021
- Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fractionEuropean Journal of Heart Failure · 2021
- Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and managementCardiovascular Diabetology · 2021
- ESC/HFA Quality of Care Centres: the ultimate frontier in unifying heart failure managementEuropean Heart Journal · 2021
- Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definitionJournal of Scleroderma and Related Disorders · 2021
- COVID ‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2021